Director, Global Value & Access Evidence Strategy

BeOne Medicines Ltd.; Basel; On-site; CHF 198,000 - 248,000; Full time

Job summary

BeOne Medicines Ltd. is seeking a Director of Value Demonstration & Access Evidence Strategy to shape global payer and HTA evidence plans across the portfolio. You will collaborate with Clinical Development, HEOR, Medical Affairs and GVAP to ensure evidence needs are integrated early in development and aligned with U.S.

and ex-U.S. requirements. The role requires deep expertise in HTA, payer strategy, and cross-functional leadership, along with strong English communication.

Qualifications

• 8+ years of experience in market access, HEOR, value & access or evidence strategy.
• Demonstrated experience supporting HTA submissions, reimbursement negotiations, evidence planning and global launch preparation.
• Excellent written and verbal communication skills in English.

Responsibilities

• Design and implement global HTA and payer evidence strategies across the product lifecycle.
• Collaborate with GVAP Asset Leads, regional access leads and HEOR to identify the evidence requirements necessary to support Joint Scientific Consultations (JSC), Joint Clinical Assessments (JCA), national HTA assessments, reimbursement submissions and pricing negotiations.
• Elicit and prioritise U.S. payer, PBM, IDN and employer evidence requirements, including comparator expectations and ICER-related needs, and ensure these are represented in Integrated Evidence Plans.
• Translate emerging requirements into actionable evidence-generation strategies aligned with development plans.

Skills

Market access

HEOR

Value & access

Evidence strategy

Leadership

English communication

Education

MSc/MPH

PhD/PharmD/MD preferred

Job description

BeOne Medicines Ltd. is seeking a Director of Value Demonstration & Access Evidence Strategy to shape global payer and HTA evidence plans across the portfolio. You will collaborate with Clinical Development, HEOR, Medical Affairs and GVAP to ensure evidence needs are integrated early in development and aligned with U.S.

and ex-U.S. requirements. The role requires deep expertise in HTA, payer strategy, and cross-functional leadership, along with strong English communication.